DK1874766T3 - Krystallinsk form af en quinolinon-carboxamid-forbindelse - Google Patents

Krystallinsk form af en quinolinon-carboxamid-forbindelse

Info

Publication number: DK1874766T3
Authority: DK; Denmark
Prior art keywords: quinolinone; crystalline form; carboxamide compound; carboxamide; compound
Prior art date: 2005-04-06

Application number

DK06740692.6T

Other languages

English (en)

Inventor

Paul R Fatheree

Adam Goldblum

Robert Chao

Daniel Genov

S Derek Turner

Original Assignee

Theravance Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-06

Filing date

2006-04-05

Publication date

2010-12-06

2006-04-05 Application filed by Theravance Inc filed Critical Theravance Inc

2010-12-06 Application granted granted Critical

2010-12-06 Publication of DK1874766T3 publication Critical patent/DK1874766T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

DK06740692.6T 2005-04-06 2006-04-05 Krystallinsk form af en quinolinon-carboxamid-forbindelse DK1874766T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66878005P	2005-04-06	2005-04-06
PCT/US2006/012978 WO2006108127A2 (en)	2005-04-06	2006-04-05	Crystalline form of a quinolinone-carboxamide compound

Publications (1)

Publication Number	Publication Date
DK1874766T3 true DK1874766T3 (da)	2010-12-06

Family

ID=37074104

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06740692.6T DK1874766T3 (da)	2005-04-06	2006-04-05	Krystallinsk form af en quinolinon-carboxamid-forbindelse

Country Status (29)

Country	Link
US (4)	US7728004B2 (da)
EP (1)	EP1874766B1 (da)
JP (2)	JP5230407B2 (da)
KR (1)	KR101322873B1 (da)
CN (1)	CN101151264B (da)
AR (2)	AR053208A1 (da)
AT (1)	ATE479682T1 (da)
AU (1)	AU2006232129B2 (da)
BR (1)	BRPI0610657A2 (da)
CA (1)	CA2603654C (da)
CY (1)	CY1111275T1 (da)
DE (1)	DE602006016586D1 (da)
DK (1)	DK1874766T3 (da)
EA (1)	EA012115B1 (da)
ES (1)	ES2350495T3 (da)
HR (1)	HRP20100629T1 (da)
IL (1)	IL186023A (da)
MA (1)	MA29403B1 (da)
MX (1)	MX2007012438A (da)
MY (1)	MY151075A (da)
NO (1)	NO339699B1 (da)
NZ (1)	NZ561900A (da)
PE (1)	PE20061310A1 (da)
PL (1)	PL1874766T3 (da)
PT (1)	PT1874766E (da)
SI (1)	SI1874766T1 (da)
TW (1)	TWI377206B (da)
WO (1)	WO2006108127A2 (da)
ZA (1)	ZA200708071B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7063671B2 (en) *	2002-06-21	2006-06-20	Boston Scientific Scimed, Inc.	Electronically activated capture device
US7728006B2 (en) *	2004-04-07	2010-06-01	Theravance, Inc.	Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) *	2004-04-07	2011-11-01	Theravance Inc	Quinolinone-carboxamide compounds as 5-ht4 recepto
ATE441646T1 (de) *	2004-11-05	2009-09-15	Theravance Inc	5-ht4-rezeptoragonistenverbindungen
EP1807423B1 (en)	2004-11-05	2009-05-20	Theravance, Inc.	Quinolinone-carboxamide compounds
TWI377206B (en) *	2005-04-06	2012-11-21	Theravance Inc	Crystalline form of a quinolinone-carboxamide compound
EP1945632B1 (en)	2005-11-08	2013-09-18	Vertex Pharmaceuticals Incorporated	Heterocyclic modulators of atp-binding cassette transporters
AU2008254999A1 (en) *	2007-05-17	2008-11-27	Theravance, Inc.	Prokinetic agent for bowel preparation
CH698729B1 (de) *	2007-05-30	2009-10-15	Cerbios Pharma Sa	Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
SI2225230T1 (sl) *	2007-12-07	2017-03-31	Vertex Pharmaceuticals Incorporated	Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
CA2758321A1 (en)	2009-04-13	2010-10-21	Theravance, Inc.	5-ht4 receptor agonist compounds for treatment of cognitive disorders
JP2013518085A (ja)	2010-02-01	2013-05-20	ノバルティスアーゲー	ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
AR080056A1 (es)	2010-02-01	2012-03-07	Novartis Ag	Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja)	2010-02-02	2015-07-15	ノバルティスアーゲー	Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
HRP20211752T1 (hr)	2010-04-07	2022-02-18	Vertex Pharmaceuticals Incorporated	Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
WO2013112804A1 (en)	2012-01-25	2013-08-01	Vertex Pharmaceuticals Incorporated	Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
JP6963896B2 (ja)	2013-11-12	2021-11-10	バーテックスファーマシューティカルズインコーポレイテッドVertex Pharmaceuticals Incorporated	Ｃｆｔｒ媒介性疾患の処置のための医薬組成物を調製する方法
BR112020000482A2 (pt)	2017-07-31	2020-07-21	Theravance Biopharma R&D Ip, Llc	métodos de tratamento de sintomas de gastroparesia usando velusetrag
US10570127B1 (en)	2018-11-05	2020-02-25	Renexxion, Llc	Material and methods for the treatment of gastro-intestinal disorders
EP4590303A1 (en) *	2022-09-20	2025-07-30	Alfasigma S.p.A.	Velusetrag for use in the treatment of chronic intestinal pseudo-obstruction (cipo)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3122671B2 (ja) *	1990-05-23	2001-01-09	協和醗酵工業株式会社	複素環式化合物
DE69113284T2 (de) *	1990-12-28	1996-02-22	Kyowa Hakko Kogyo Co., Ltd., Tokio/Tokyo	Chinolinderivat.
EP0670319A4 (en) *	1992-11-20	1996-01-17	Thaisho Pharmaceutical Co Ltd	HETEROCYCLIC COMPOUNDS.
JP3829879B2 (ja) *	1994-05-18	2006-10-04	大正製薬株式会社	キノリンカルボン酸誘導体
TW402591B (en) *	1997-07-11	2000-08-21	Janssen Pharmaceutica Nv	Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
US7105195B2 (en) *	2003-07-25	2006-09-12	General Mills, Inc.	Reduced trans fat product
DE602004026095D1 (de)	2003-11-24	2010-04-29	Pfizer	Chinoloncarbonsäureverbindungen mit 5-ht4-rezeptoragonistischer wirkung
TWI351282B (en) *	2004-04-07	2011-11-01	Theravance Inc	Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) *	2004-04-07	2010-06-01	Theravance, Inc.	Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
ATE441646T1 (de) *	2004-11-05	2009-09-15	Theravance Inc	5-ht4-rezeptoragonistenverbindungen
EP1807423B1 (en) *	2004-11-05	2009-05-20	Theravance, Inc.	Quinolinone-carboxamide compounds
WO2006088988A1 (en)	2005-02-17	2006-08-24	Theravance, Inc.	Crystalline form of an indazole-carboxamide compound
NZ560828A (en) *	2005-03-02	2011-01-28	Theravance Inc	Quinolinone compounds as 5-HT4 receptor agonists
TWI377206B (en) *	2005-04-06	2012-11-21	Theravance Inc	Crystalline form of a quinolinone-carboxamide compound

2006
- 2006-03-27 TW TW095110607A patent/TWI377206B/zh not_active IP Right Cessation
- 2006-04-03 PE PE2006000360A patent/PE20061310A1/es not_active Application Discontinuation
- 2006-04-03 MY MYPI20061482 patent/MY151075A/en unknown
- 2006-04-05 BR BRPI0610657-9A patent/BRPI0610657A2/pt not_active Application Discontinuation
- 2006-04-05 HR HR20100629T patent/HRP20100629T1/hr unknown
- 2006-04-05 MX MX2007012438A patent/MX2007012438A/es active IP Right Grant
- 2006-04-05 DK DK06740692.6T patent/DK1874766T3/da active
- 2006-04-05 KR KR1020077025632A patent/KR101322873B1/ko not_active Expired - Lifetime
- 2006-04-05 JP JP2008505559A patent/JP5230407B2/ja not_active Expired - Lifetime
- 2006-04-05 AU AU2006232129A patent/AU2006232129B2/en not_active Expired
- 2006-04-05 PL PL06740692T patent/PL1874766T3/pl unknown
- 2006-04-05 WO PCT/US2006/012978 patent/WO2006108127A2/en not_active Ceased
- 2006-04-05 EP EP06740692A patent/EP1874766B1/en not_active Expired - Lifetime
- 2006-04-05 DE DE602006016586T patent/DE602006016586D1/de not_active Expired - Lifetime
- 2006-04-05 EA EA200702161A patent/EA012115B1/ru not_active IP Right Cessation
- 2006-04-05 AT AT06740692T patent/ATE479682T1/de active
- 2006-04-05 SI SI200630833T patent/SI1874766T1/sl unknown
- 2006-04-05 PT PT06740692T patent/PT1874766E/pt unknown
- 2006-04-05 US US11/398,119 patent/US7728004B2/en active Active
- 2006-04-05 NZ NZ561900A patent/NZ561900A/en unknown
- 2006-04-05 ES ES06740692T patent/ES2350495T3/es not_active Expired - Lifetime
- 2006-04-05 CA CA2603654A patent/CA2603654C/en not_active Expired - Lifetime
- 2006-04-05 CN CN2006800107676A patent/CN101151264B/zh not_active Expired - Lifetime
- 2006-04-06 AR ARP060101375A patent/AR053208A1/es not_active Application Discontinuation
2007
- 2007-09-18 IL IL186023A patent/IL186023A/en active IP Right Grant
- 2007-09-19 ZA ZA200708071A patent/ZA200708071B/xx unknown
- 2007-10-25 MA MA30317A patent/MA29403B1/fr unknown
- 2007-11-02 NO NO20075574A patent/NO339699B1/no not_active IP Right Cessation
2010
- 2010-04-13 US US12/759,080 patent/US8658671B2/en active Active
- 2010-11-25 CY CY20101101076T patent/CY1111275T1/el unknown
2012
- 2012-05-17 JP JP2012113464A patent/JP2012153725A/ja not_active Withdrawn
2014
- 2014-01-08 US US14/150,059 patent/US9126994B2/en not_active Expired - Lifetime
2015
- 2015-08-03 US US14/816,237 patent/US9402840B2/en not_active Expired - Lifetime
2017
- 2017-11-01 AR ARP170103029A patent/AR110019A2/es unknown

Also Published As

Publication number	Publication date
KR101322873B1 (ko)	2013-10-30
EA200702161A1 (ru)	2008-04-28
CN101151264A (zh)	2008-03-26
US7728004B2 (en)	2010-06-01
EP1874766A2 (en)	2008-01-09
DE602006016586D1 (de)	2010-10-14
WO2006108127A2 (en)	2006-10-12
HK1110866A1 (en)	2008-07-25
TW200643020A (en)	2006-12-16
MY151075A (en)	2014-03-31
US9126994B2 (en)	2015-09-08
US20160095849A1 (en)	2016-04-07
PT1874766E (pt)	2010-11-30
ATE479682T1 (de)	2010-09-15
EA012115B1 (ru)	2009-08-28
KR20070116988A (ko)	2007-12-11
US20060229332A1 (en)	2006-10-12
EP1874766B1 (en)	2010-09-01
TWI377206B (en)	2012-11-21
NO20075574L (no)	2007-11-02
JP5230407B2 (ja)	2013-07-10
PL1874766T3 (pl)	2011-02-28
JP2008535848A (ja)	2008-09-04
AR053208A1 (es)	2007-04-25
NZ561900A (en)	2010-12-24
CN101151264B (zh)	2011-07-06
PE20061310A1 (es)	2007-01-23
WO2006108127A3 (en)	2007-01-04
AU2006232129A1 (en)	2006-10-12
AU2006232129B2 (en)	2012-07-12
ZA200708071B (en)	2008-10-29
US8658671B2 (en)	2014-02-25
US9402840B2 (en)	2016-08-02
SI1874766T1 (sl)	2010-12-31
MX2007012438A (es)	2007-12-05
IL186023A0 (en)	2008-01-20
US20140256769A1 (en)	2014-09-11
MA29403B1 (fr)	2008-04-01
BRPI0610657A2 (pt)	2010-07-13
ES2350495T3 (es)	2011-01-24
CY1111275T1 (el)	2015-08-05
AR110019A2 (es)	2019-02-13
CA2603654A1 (en)	2006-10-12
JP2012153725A (ja)	2012-08-16
HRP20100629T1 (hr)	2010-12-31
US20100197728A1 (en)	2010-08-05
NO339699B1 (no)	2017-01-23
IL186023A (en)	2011-09-27
CA2603654C (en)	2014-05-27

Publication	Publication Date	Title
DK1778672T3 (da)	2013-03-25	Krystallinsk form af en biphenylforbindelse
DK1856050T3 (da)	2010-02-01	Krystallinske former af en biphenylforbindelse
CY2024008I1 (el)	2024-09-20	Συνδυασμος ο οποιος περιλαμβανει εναν ευσταθη κρυσταλλο μιας ενωσης 4-οξοκινολινης
DK1874766T3 (da)	2010-12-06	Krystallinsk form af en quinolinon-carboxamid-forbindelse
DK1937071T3 (da)	2011-11-28	Krystallinske modifikationer af pyraclostrobin
EP2003132A4 (en)	2010-05-12	HETERO COMPOUND
DK1924531T3 (da)	2014-02-10	Fjernelse af ammonium/ammoniak fra en strøm
DK3061467T3 (da)	2019-01-02	Sårforbinding med en bakterieadsorberende sammensætning
EP1958592A4 (en)	2014-05-14	intraocular lens
FR13C0071I2 (fr)	2015-11-20	Compose diarylhydantoine
DK1919907T3 (da)	2011-04-18	Heterocyklisk forbindelse
EP1873153A4 (en)	2009-09-30	HETEROCYCLIC CONNECTION
DK1877568T3 (da)	2012-12-03	Hydrolysering af arabinoxylan
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DK2331538T3 (da)	2014-06-02	Krystallinske former af en 2-thiazolyl-4-quinolinyl-oxy-derivat, en potent HCV-inhibitor
DK1778618T3 (da)	2014-03-10	Syntese af triethylentetraminer
DK2262793T3 (da)	2012-10-15	Krystallinske former af nilotinib-hci
EP2123654A4 (en)	2011-05-11	pyrazolopyrimidine compound
DK2083629T3 (da)	2011-09-26	Krystallinsk modifikation af fipronil
EP1985620A4 (en)	2012-08-15	10a-azalide compound
DK1963302T3 (da)	2013-04-02	Polymorfer af en C-MET/HGFR-inhibitor
BRPI0814801A2 (pt)	2017-03-28	composto de piridazina cristalina
EP1876179A4 (en)	2009-09-09	THIENOPYRIMIDONVERBINDUNGEN
DK2371818T3 (da)	2013-03-25	Hydroxybenzoatsalte af metanikotinforbindelser
ATE443056T1 (de)	2009-10-15	Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen